Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Notification of managers’ transactions
Notification of managers’ transactions
Notification of managers’ transactions
Ørsted completes rights issue
Ørsted completes rights issue
Ørsted completes rights issue
Partners Group expands North America presence with new office in Montreal
Partners Group expands North America presence with new office in Montreal
Partners Group expands North America presence with new office in Montreal
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Atmos Energy Corporation to Host Fiscal 2025 Year End Earnings Conference Call on November 6, 2025
Atmos Energy Corporation to Host Fiscal 2025 Year End Earnings Conference Call on November 6, 2025


Atmos Energy Corporation (NYSE: ATO) will host a conference call on Thursday, November 6, 2025, at 10 a.m. Eastern to review the company’s Fiscal 2025 financial results, establish guidance for

Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest


Bayer is proud to announce that Cornfed Farms, a fourth-generation farm operated by the Mohr family, has been designated as the first Bayer ForwardFarm site in the Midwest and the only ForwardFarm

Turkiye Garanti Bankasi A.S.: Annoucement about the issuance of subordinated eurobond abroad
Turkiye Garanti Bankasi A.S.: Annoucement about the issuance of subordinated eurobond abroad
Turkiye Garanti Bankasi A.S.: Annoucement about the issuance of subordinated eurobond abroad
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease


Bayer AG and its wholly owned, independently operated subsidiary BlueRock Therapeutics LP, a clinical stage cell therapy company, today announced positive 36-month data from exPDite, a Phase I

Announcement in relation to European Commission Clearance and Date of Court Hearing to sanction scheme
Announcement in relation to European Commission Clearance and Date of Court Hearing to sanction scheme
Announcement in relation to European Commission Clearance and Date of Court Hearing to sanction scheme
Result of rights issue
Result of rights issue
Result of rights issue
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
BAT: 70 % der Experten halten Nikotin fälschlicherweise für die Ursache von Krankheiten, die durch Rauchen bedingt sind
BAT: 70 % der Experten halten Nikotin fälschlicherweise für die Ursache von Krankheiten, die durch Rauchen bedingt sind


Laut BAT zeigt eine neue Studie unter Strategieexperten in 15 unterschiedlichen Regionen, dass Nikotin nach wie vor irrtümlicherweise für Gesundheitsrisiken verantwortlich gemacht wird - obwohl es

BAT Announces 70% of Policy Experts Continue to Misidentify Nicotine as Primary Cause of Smoking-related Disease
BAT Announces 70% of Policy Experts Continue to Misidentify Nicotine as Primary Cause of Smoking-related Disease


BAT announces that a new multi-market survey of policy experts across 15 different territories reveals that erroneous perceptions of nicotine health risks continue to persist, despite both the

Notification of manager’s transaction
Notification of manager’s transaction
Notification of manager’s transaction
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
Turkiye Garanti Bankasi A.S.: Board of Directors Resolution Regarding the Issuance of Asset-Backed Securities
Turkiye Garanti Bankasi A.S.: Board of Directors Resolution Regarding the Issuance of Asset-Backed Securities
Turkiye Garanti Bankasi A.S.: Board of Directors Resolution Regarding the Issuance of Asset-Backed Securities
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Partners Group and CVC agree partnership to drive next phase of growth at International Schools Partnership, a leading global K-12 school platform
Partners Group and CVC agree partnership to drive next phase of growth at International Schools Partnership, a leading global K-12 school platform
Partners Group and CVC agree partnership to drive next phase of growth at International Schools Partnership, a leading global K-12 school platform
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2025 financial results after market close on Thursday, October 30, 2025. Management will hold a conference call

Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Verisign to Report Third Quarter 2025 Financial Results
Verisign to Report Third Quarter 2025 Financial Results


VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that its live earnings teleconference for the third quarter

Dalata Hotel Group PLC: TVR-Total Voting Rights
Dalata Hotel Group PLC: TVR-Total Voting Rights
Dalata Hotel Group PLC: TVR-Total Voting Rights
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Dalata Hotel Group PLC: HOL-Holding(s) in Company*